Decreased body clearance of diflunisal in renal insufficiency--an alternative explanation.
作者信息
Levy G
出版信息
Br J Clin Pharmacol. 1979 Dec;8(6):601. doi: 10.1111/j.1365-2125.1979.tb01055.x.
Abstract
摘要
相似文献
1
Decreased body clearance of diflunisal in renal insufficiency--an alternative explanation.肾功能不全时双氟尼酸的体内清除率降低——另一种解释。
Br J Clin Pharmacol. 1979 Dec;8(6):601. doi: 10.1111/j.1365-2125.1979.tb01055.x.
2
Decreased clearance of diflunisal in renal insufficiency--an alternative explanation.肾功能不全时双氯芬酸清除率降低——另一种解释。
Br J Clin Pharmacol. 1980 Aug;10(2):185-6. doi: 10.1111/j.1365-2125.1980.tb01744.x.
3
Biliary excretion of diflunisal conjugates in patients with T-tube drainage.
Eur J Clin Pharmacol. 1988;34(4):423-6. doi: 10.1007/BF00542448.
4
Failure of alkaline diuresis to enhance diflunisal elimination.碱性利尿未能增强二氟尼柳的消除。
Br J Clin Pharmacol. 1980 Aug;10(2):163-5. doi: 10.1111/j.1365-2125.1980.tb01734.x.
5
Glucuronidation and disposition of drug glucuronides in patients with renal failure. A review.肾衰竭患者中药物的葡萄糖醛酸化及葡萄糖醛酸苷的处置。综述。
Drug Metab Dispos. 1982 Jan-Feb;10(1):87-9.
6
Pharmacokinetics of diflunisal elimination in patients with renal insufficiency [proceedings].
Br J Clin Pharmacol. 1977 Oct;4(5):645P-646P. doi: 10.1111/j.1365-2125.1977.tb00817.x.
7
Diflunisal disposition and hypouricemic response in osteoarthritis.
Clin Pharmacol Ther. 1983 Jun;33(6):813-21. doi: 10.1038/clpt.1983.111.
8
Both phenolic and acyl glucuronidation pathways of diflunisal are impaired in liver cirrhosis.
Eur J Clin Pharmacol. 1992;42(5):471-4. doi: 10.1007/BF00314852.
9
Effect of dose on the glucuronidation and sulphation kinetics of diflunisal in man: single dose studies.剂量对人双氯芬酸葡萄糖醛酸化和硫酸化动力学的影响：单剂量研究
Br J Clin Pharmacol. 1988 Jul;26(1):31-9. doi: 10.1111/j.1365-2125.1988.tb03360.x.
10
引用本文的文献
1
Decreased clearance of diflunisal in renal insufficiency--an alternative explanation.肾功能不全时双氯芬酸清除率降低——另一种解释。
Br J Clin Pharmacol. 1980 Aug;10(2):185-6. doi: 10.1111/j.1365-2125.1980.tb01744.x.
2
Drug metabolites in renal failure: pharmacokinetic and clinical implications.肾衰竭中的药物代谢产物：药代动力学及临床意义
Clin Pharmacokinet. 1981 Sep-Oct;6(5):329-45. doi: 10.2165/00003088-198106050-00001.
3
Diflunisal: a review of its pharmacological properties and therapeutic use in pain and musculoskeletal strains and sprains and pain in osteoarthritis.二氟尼柳：对其药理特性以及在疼痛、肌肉骨骼拉伤和扭伤及骨关节炎疼痛中的治疗用途的综述
Drugs. 1980 Feb;19(2):84-106. doi: 10.2165/00003495-198019020-00002.
4
Metabolism of amitriptyline in patients with chronic renal failure.慢性肾衰竭患者中阿米替林的代谢
Eur J Clin Pharmacol. 1984;26(2):227-32. doi: 10.1007/BF00630290.
5
Impaired elimination of lorazepam following subchronic administration in two patients with renal failure.两名肾衰竭患者亚慢性给药后劳拉西泮清除受损。
Br J Clin Pharmacol. 1981 Nov;12(5):749-51. doi: 10.1111/j.1365-2125.1981.tb01300.x.
6
Pharmacokinetic profile of indoprofen in elderly subjects.吲哚美辛在老年受试者中的药代动力学特征。
Br J Clin Pharmacol. 1986 Dec;22(6):721-4. doi: 10.1111/j.1365-2125.1986.tb02964.x.
7
Biliary excretion of diflunisal conjugates in patients with T-tube drainage.
Eur J Clin Pharmacol. 1988;34(4):423-6. doi: 10.1007/BF00542448.
8
Influence of renal failure, rheumatoid arthritis and old age on the pharmacokinetics of diflunisal.肾衰竭、类风湿关节炎及老年对二氟尼柳药代动力学的影响。
Eur J Clin Pharmacol. 1989;36(2):165-74. doi: 10.1007/BF00609190.
9
Diflunisal and its conjugates in patients with renal failure.双氟尼酸及其结合物在肾衰竭患者中的情况。
Br J Clin Pharmacol. 1991 May;31(5):546-50. doi: 10.1111/j.1365-2125.1991.tb05578.x.
10
Clinical pharmacokinetics of ketorolac tromethamine.酮咯酸氨丁三醇的临床药代动力学。
Clin Pharmacokinet. 1992 Dec;23(6):415-27. doi: 10.2165/00003088-199223060-00003.
本文引用的文献
1
Biotransformation of diflunisal and renal excretion of its glucuronides in renal insufficiency.双氯芬酸在肾功能不全患者体内的生物转化及其葡糖醛酸苷的肾排泄
Br J Clin Pharmacol. 1979 Mar;7(3):273-82. doi: 10.1111/j.1365-2125.1979.tb00932.x.
2
Physiological disposition and metabolism of 5-(2',4'-difluorophenyl)salicyclic acid, a new salicylate.新型水杨酸盐5-（2'，4'-二氟苯基）水杨酸的生理处置与代谢
Drug Metab Dispos. 1975 Nov-Dec;3(6):453-66.
Zotero 插件